Cargando…

Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic

BACKGROUND: Early clinical severity assessments during the 2009 influenza A H1N1 pandemic (pH1N1) overestimated clinical severity due to selection bias and other factors. We retrospectively investigated how to use data from the International Network for Strategic Initiatives in Global HIV Trials, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simonsen, Lone, Higgs, Elizabeth, Taylor, Robert J, Wentworth, Deborah, Cozzi-Lepri, Al, Pett, Sarah, Dwyer, Dominic E, Davey, Richard, Lynfield, Ruth, Losso, Marcelo, Morales, Kathleen, Glesby, Marshall J, Weckx, Jozef, Carey, Dianne, Lane, Cliff, Lundgren, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Articles and Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248856/ https://www.ncbi.nlm.nih.gov/pubmed/29746631 http://dx.doi.org/10.1093/cid/ciy088

Ejemplares similares

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015
por: Dwyer, Dominic E, et al.
Publicado: (2017)

Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies
por: Lynfield, Ruth, et al.
Publicado: (2014)

The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies
por: Davey, Richard T., et al.
Publicado: (2013)

A bioinformatic approach to identify new potential resistance relevant amino acid substitutions (AAS) in HIV-1 protease (H1P)
por: Frederiksen, Casper M, et al.
Publicado: (2009)

Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy
por: Grund, Birgit, et al.
Publicado: (2016)

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study
por: Pett, Sarah L, et al.
Publicado: (2017)

Long term effectiveness of once-daily unboosted atazanavir plus abacavir/lamivudine as a switch strategy in subjects with virological suppression
por: Llibre, Josep M, et al.
Publicado: (2014)

Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failure
por: Schultze, Anna, et al.
Publicado: (2014)

Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death
por: Casadellà, Maria, et al.
Publicado: (2017)

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
por: Davey, Richard T, et al.
Publicado: (2019)

Another piece in the COVID-19 treatment puzzle
por: Mussini, Cristina, et al.
Publicado: (2022)

Can Linear Regression Modeling Help Clinicians in the Interpretation of Genotypic Resistance Data? An Application to Derive a Lopinavir-Score
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2011)

Immuno-Virological Discordance and the Risk of Non-AIDS and AIDS Events in a Large Observational Cohort of HIV-Patients in Europe
por: Zoufaly, Alexander, et al.
Publicado: (2014)

Deep-sequencing of viral genomes from a large and diverse cohort of treatment-naive HIV-infected persons shows associations between intrahost genetic diversity and viral load
por: Gabrielaite, Migle, et al.
Publicado: (2023)

1601 Screening for chronic obstructive pulmonary disease (COPD) in an urban HIV clinic
por: Shirley, Daniel, et al.
Publicado: (2014)

Signals were broadly positive for months, but never definitive: the tocilizumab story
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2022)

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens
por: Cozzi‐Lepri, A, et al.
Publicado: (2017)

Plasma HIV-1 tropism and risk of short-term clinical progression to AIDS or death
por: Casadellà Fontdevila, Maria, et al.
Publicado: (2014)

Observational cohort study of rilpivirine (RPV) utilization in Europe
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2022)

3394 Alpha-1-acid glycoprotein as outcome, independent predictor, and effect modifier in a randomized, placebo-controlled, factorial trial of recombinant human growth hormone and rosiglitazone in people living with HIV
por: Gannon, Bryan M., et al.
Publicado: (2019)

Cross-sectional study of correlates and prevalence of functional and high-risk multimorbidity in an academic HIV practice in New York City
por: Siegler, Eugenia, et al.
Publicado: (2021)

Re: ‘Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness’ by Wolkewitz et al.
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2021)

The Potential of Antimicrobials to Induce Thrombocytopenia in Critically Ill Patients: Data from a Randomized Controlled Trial
por: Johansen, Maria Egede, et al.
Publicado: (2013)

Does helminthic infection alter the clinical course of HTLV-1 infection?
por: Sundberg, Michael A, et al.
Publicado: (2011)

Older people with HIV are an essential part of the continuum of HIV care
por: Siegler, Eugenia L, et al.
Publicado: (2018)

Aging-Related Concerns of People Living with HIV Referred for Geriatric Consultation
por: Siegler, Eugenia L, et al.
Publicado: (2021)

Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study
por: Podlekareva, Daria N, et al.
Publicado: (2012)

Factors Associated with D-Dimer Levels in HIV-Infected Individuals
por: Borges, Álvaro H., et al.
Publicado: (2014)

Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study
por: Llibre, Josep M., et al.
Publicado: (2016)

Aging With HIV: Inflammation Is Associated With Pain, Poorer Physical Function, and Frailty
por: Derry, Heather, et al.
Publicado: (2020)

1431. Evaluating Physician Decision Making in Inpatient Antibiotic Prescription for Suspected Urinary Tract Infection
por: Arar, Celine, et al.
Publicado: (2021)

Reply to Manfredi
por: Lichtner, Miriam, et al.
Publicado: (2015)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Tocilizumab in COVID-19: finding the optimal route and dose – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Does Seasonal Influenza Vaccination Increase the Risk of Illness with the 2009 A/H1N1 Pandemic Virus?
por: Viboud, Cécile, et al.
Publicado: (2010)

Pandemics, Severity, and Context—Some Loose Ends
por: Simonsen, Lone, et al.
Publicado: (2017)

Timely estimates of influenza A H7N9 infection severity
por: Viboud, Cécile, et al.
Publicado: (2013)

A comprehensive look at the COVID-19 pandemic death toll
por: Simonsen, Lone, et al.
Publicado: (2021)

Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study
por: Dickinson, Laura, et al.
Publicado: (2015)

Pain Is Associated With Depressive Symptoms, Inflammation, and Poorer Physical Function in Older Adults With HIV
por: Derry-Vick, Heather M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gi74ge10732mvlsnns1k53u4p6